Multiple Choice
Rifampin is a nonspecific CYP450 inducer that may:
A) Lead to toxic levels of rifampin and must be monitored closely
B) Cause toxic levels of drugs, such as oral contraceptives, when coadministered
C) Induce the metabolism of drugs, such as oral contraceptives, leading to therapeutic failure
D) Cause nonspecific changes in drug metabolism
Correct Answer:
Verified
Correct Answer:
Verified
Q2: Ultra-rapid metabolizers of drugs may have:<br>A) To
Q3: Genetic polymorphisms account for differences in metabolism,
Q4: Carbamazepine has a Black Box Warning recommending
Q5: Warfarin resistance may be seen in patients
Q6: A provider may consider testing for CYP2D6
Q7: Patients who have a poor metabolism phenotype
Q9: Up to 21% of Asians are ultra-rapid
Q10: Inhibition of P-glycoprotein by a drug such
Q11: Pharmacogenetic testing is required by the U.S.
Q12: Genetic testing for VCORC1 mutation to assess